SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Madrigal Pharmaceuticals
MDGL 418.90-2.0%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (93)4/12/2019 12:31:27 PM
From: keokalani'nui  Read Replies (1) of 138
 
Thanks for sharing your thoughts.

A year ago I thought NASH market (if it achieves dream potential) would be captured by a few small pioneers with magic bullet who could fight off bigger resources. By the time mdgl P3 reports, competition may look increasingly like a dog fight. I have significantly reduced my mdgl position simply due to all the bad macro and global risks that within 2 years are sure to hurt all stocks between now and then, even though mdgl is certainly for sale at a price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News